Anti-viral therapy for chronic hepatitis B and its long-term prognosis: Chinese guideline for prevention and treatment of chronic hepatitis B (2019 version)-interpretation of update pointsSHENG Qiu-ju, HAN Chao, DING Yang, DOU Xiao-guang441-445
Natural history of chronic HBV infection and adverse clinical outcomesWU Wen-yu, LI Wei-na, NING Qin446-450
Research progress of antiviral end-point markers in chronic hepatitis BLIU Zhi-hong, LING Xiao-zhang, JIANG Jian-ning451-456
Progress in the study of antiviral therapy promotes recompensation of decompensated hepatitis B-related liver cirrhosisLUO Chang-ling, CAO Ying, XIE Wen457-460,465
Hematological changes in COVID-19 patients: early indications of diagnosis and progressionLIU Xiao-qing, ZHANG Run, HE Guang-sheng461-465
Efficacy and safety of tenofovir alafenamide fumarate in pregnant women at HBV-infected immune-tolerant phaseTIAN Wen-yue, SHENG Qiu-ju, ZHANG Chong, DOU Xiao-guang, DING Yang466-470
Clinical features of cytomegalovirus pneumonia in non-AIDS, non-transplanted immunocompromised patientsZHAN Yang-qing, ZENG Pei-ying, CHENG Lin-ling, PAN Feng-yu, CHEN Rong-chang, YE Feng471-475
Clinical significance of body mass index in psoriatic arthritisSONG Hai-ning, LI Bei-bei, YANG Ping-ting476-480
Diagnostic value of echocardiography combined with cardiac markers in patients with sepsis-induced cardiac insufficiencyCHEN Su-mei, Gulibahaer, TIAN Pei-gang, CHENG Qing-hong, WENG Guo-peng, WANG Yong-chun481-486
Expression of urinary exosomes in patients with idiopathic membranous nephropathy and its clinical significanceLI Ru-meng, LI Chai, GENG Le, XU Tian, WANG Li-li, ZHOU Hua, ZHANG Bei-ru, SUN Guang-ping, SU Xue-song, WANG Yan-qiu487-492
